Cargando…
Multi-Morbidity in the Older Person: An Examination of Polypharmacy and Socioeconomic Status
There has been increased focus on clinically managing multi-morbidity in the older population, but it can be challenging to find appropriate paradigm that addresses the socio-economic burden and risk for polypharmacy. The Commission on Social Determinants of Health (CSDH) has examined the need for i...
Autor principal: | Nwadiugwu, Martin C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7848189/ https://www.ncbi.nlm.nih.gov/pubmed/33537273 http://dx.doi.org/10.3389/fpubh.2020.582234 |
Ejemplares similares
-
Frailty and the Risk of Polypharmacy in the Older Person: Enabling and Preventative Approaches
por: Nwadiugwu, Martin C.
Publicado: (2020) -
Inflammatory Activities in Type 2 Diabetes Patients With Co-morbid Angiopathies and Exploring Beneficial Interventions: A Systematic Review
por: Nwadiugwu, Martin C.
Publicado: (2021) -
Polypharmacy, chronic kidney disease, and mortality among older adults: A prospective study of National Health and nutrition examination survey, 1999–2018
por: Wang, Xiaowen, et al.
Publicado: (2023) -
The impact of socioeconomic status and sleep quality on the prevalence of multimorbidity in older adults
por: Xue, Benli, et al.
Publicado: (2022) -
Race/Ethnicity, Socioeconomic Status, and Polypharmacy among Older Americans
por: Assari, Shervin, et al.
Publicado: (2019)